BRIAN PRATT: Open Payments
NPI 1679861256 · CLAYTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,207 in 106 payments from 19 companies in 2025. Trend: 2023 $1,328 · 2024 $4,866 · 2025 $20,207
Speaker / faculty: $10,423Consulting: $5,475Travel & lodging: $2,238Food & beverage: $2,071
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 32 | $9,685 |
| Eli Lilly and Company | 2 | $5,475 |
| ABBVIE INC. | 30 | $4,076 |
| Novo Nordisk Inc | 9 | $336 |
| Vanda Pharmaceuticals Inc. | 5 | $118 |
| Amgen Inc. | 5 | $91 |
| PFIZER INC. | 3 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| Braeburn Inc. | 2 | $53 |
| Lilly USA, LLC | 5 | $50 |
Products named: SUBLOCADE, VRAYLAR, Wegovy, Ozempic, FANAPT, OTEZLA, LEQVIO, BRIXADI.
Industry payments across GA — which companies pay providers there.
